#3 - Kimberly Clark (NYSE:KMB)
Kimberly Clark (KMB)
P/E Ratio: 20.94
Dividend Yield: 2.97%
Kimberly Clark (NYSE: KMB) has rallied over 25% since the selloff in March. This just goes to show that the company’s portfolio of personal care products continues to be in high demand. But there’s another reason to own the stock. As more hospitals are opening for elective surgeries, it should provide a boost for the company’s surgical and medical instruments division.
The company is beginning to see the benefit of a restructuring plan that it began in 2018. The company is already reporting higher operating margins even as the company has had to put the plan on hold due to the pandemic.
The P/E ratio and current price target from 11 analysts suggest that investors shouldn’t be expecting significant growth. However, you’re buying a blue-chip stock like Kimberly Clark for the dividend. And the company delivers in that regard. In addition to the dividend yield that is right around 2.97%, it has increased the payout every year for the last 47 years. That can’t be overlooked at a time when many companies are reducing or suspending dividends.
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More - Current Price
- $139.14
- Consensus Rating
- Hold
- Ratings Breakdown
- 6 Buy Ratings, 7 Hold Ratings, 2 Sell Ratings.
- Consensus Price Target
- $149.93 (7.8% Upside)
